CN1368122A - Nano antivirus medicine and its preparing process - Google Patents
Nano antivirus medicine and its preparing process Download PDFInfo
- Publication number
- CN1368122A CN1368122A CN 01102353 CN01102353A CN1368122A CN 1368122 A CN1368122 A CN 1368122A CN 01102353 CN01102353 CN 01102353 CN 01102353 A CN01102353 A CN 01102353A CN 1368122 A CN1368122 A CN 1368122A
- Authority
- CN
- China
- Prior art keywords
- nanometer
- nano
- parts
- medicine
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 230000002155 anti-virotic effect Effects 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims description 13
- 239000000463 material Substances 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 11
- 241000605447 Anemarrhena Species 0.000 claims abstract description 6
- 238000001694 spray drying Methods 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 20
- 239000010231 banlangen Substances 0.000 claims description 9
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 235000014375 Curcuma Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 235000008504 concentrate Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 230000008676 import Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000003094 microcapsule Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 229940100688 oral solution Drugs 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 2
- 239000003390 Chinese drug Substances 0.000 claims 2
- 244000164439 Curcuma angustifolia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 241000334160 Isatis Species 0.000 abstract 1
- 229930191283 anemarrhena Natural products 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 7
- 230000000840 anti-viral effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 241000407170 Curcuma Species 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000034579 Acute haemorrhagic conjunctivitis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 239000011858 nanopowder Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000031973 Conjunctivitis infective Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
A nanometre (0.1-200 nm) antivirus medicine is prepared from the nanometre powders of 9 Chinese medicinal materials including gypsum, anemarrhena rhizome, isatis root, etc. through proportioning, microwave extracting, pressure reduction concentrating and supersonic-jet spray drying. Its grain fineness reaches 1200-1500 meshes and grain diameters are 0.1-200 nm. Its advantages are high biological utilization rate and high curative effect.
Description
The present invention relates to the nano antivirus medicine of a kind of clearing heat and expelling damp, removing pathogenic heat from blood and toxic substance from the body, the invention still further relates to the method for this medication preparation.
The antiviral bolt is a kind of classical Chinese patent medicine, mainly contains effects such as analgesic, antiviral, is used for anemopyretic cold, epidemic febrile disease heating and upper respiratory tract infection, influenza, parotitis, epidemic hemorrhagic conjunctivitis viral illness such as (pink eye disease).But traditional antiviral bolt uses inconvenient, and bioavailability is not high, slow curative effect.
The object of the present invention is to provide a kind of bioavailability height, solid dispersion is good, absorbs fully the nano antivirus medicine of increase evident in efficacy.
Another object of the present invention provides the preparation method of this nano antivirus medicine.
To achieve these goals, the present invention takes following technical scheme:
Medicine of the present invention is to make (consumption is a weight portion) by following component:
Nanometer Gypsum Fibrosum 50-120 part nanometer Rhizoma Anemarrhenae 15-60 part nano Radix Isatidis 120-250 part
Nanometer Fructus Forsythiae 40-90 part nanometer Radix Rehmanniae 25-80 part nanometer Rhizoma Acori Graminei 20-55 part
Nanometer Rhizoma Phragmitis 50-120 part nanometer Radix Curcumae 20-55 part nanometer Herba Pogostemonis 25-60 part
The formula optimization weight proportion scope of medicine of the present invention is:
Nanometer Gypsum Fibrosum 60-100 part nanometer Rhizoma Anemarrhenae 20-50 part nano Radix Isatidis 150-210 part
Nanometer Fructus Forsythiae 50-80 part nanometer Radix Rehmanniae 30-60 part nanometer Rhizoma Acori Graminei 25-45 part
Nanometer Rhizoma Phragmitis 60-100 part nanometer Radix Curcumae 25-45 part nanometer Herba Pogostemonis 30-50 part
The optimum weight proportioning of medicine of the present invention is:
180 parts of 35 parts of nano Radix Isatidis of 80 parts of nanometer Rhizoma Anemarrhenaes of nanometer Gypsum Fibrosum
35 parts of 45 parts of nanometer Rhizoma Acori Graminei of 65 parts of nanometer Radix Rehmanniae of nanometer Fructus Forsythiae
40 parts of 35 parts of nanometer Herba Pogostemonis of 85 parts of nanometer Radix Curcumaes of nanometer Rhizoma Phragmitis
Technical scheme of the present invention is based on the modern material technology.One of modern material Developing Trend in Technology is to develop to the more and more littler direction of yardstick.The granule of the past composition material, its size all are at micron or more than the millimeter magnitude, and have occurred the material to the nanoscale development now.Because extremely refinement of granule, the shared percentage by volume of crystal boundary increases, and makes some performance of material that outstanding variation take place.
The property of nano material be since special construction----the material grains size of nano material less than the ultra-micro powder of 100nm, its body surface area is very big, the atom number ratio at crystal boundary place makes it to produce four big effects up to 15--50%: i.e. small-size effect, quantum effect (containing macro quanta tunnel effect), skin effect and interfacial effect.Thereby has the not available physical and chemical performance of traditional material.Nanotechnology will bring a technological revolution of the field of Chinese medicines.
One of method of above-mentioned each component being made medicine of the present invention is:
1. divide and get the Chinese crude drug of respectively distinguishing the flavor of, be processed into the common Chinese decoction pieces according to process of preparing Chinese medicine of Chinese Pharmacopoeia version in 2000.
2. divide and get the common Chinese decoction pieces of respectively distinguishing the flavor of, be processed into the nanometer prepared slices of Chinese crude drugs, its method comprises the following steps:
1. the common Chinese decoction pieces is placed extraction pot, solubilizer also imports microwave extracting, makes its speed with 20--30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃--and 60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃--60 ℃, the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters of effluxvelocities--990 meter per seconds, at 30 ℃--60 ℃ of temperature, under 0 to the 0.05MPa pressure,, promptly make the nanometer prepared slices of Chinese crude drugs with hypersonic velocity instantaneous jet drying.
3. the nanometer prepared slices of Chinese crude drugs (powder) are prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent standard, make pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution.
Two of medicine method for making of the present invention is:
1. be equipped with whole common Chinese decoction pieces in the proportioning ratio, place extraction pot, solubilizer also imports microwave extracting, makes its speed with 20--30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃-60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃--60 ℃, the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters of effluxvelocities--990 meter per seconds, at 30 ℃--60 ℃ of temperature, under 0 to the 0.05MPa pressure,, get the anti-virus formulation nano powder with hypersonic velocity instantaneous jet drying;
4. its nano powder is made aforementioned various preparation according to Chinese Pharmacopoeia version standard preparation in 2000.
The pharmacological effect that above-mentioned two kinds of methods are made nano antivirus medicine is identical.
A kind of important feature of the present invention is: the made drug material of the present invention has reached nanoscale, common antiviral bolt preparation material is micron or the above particle diameter of millimeter, can only cross the 80-120 mesh sieve, the drug material that the present invention is made, particle diameter is at 0.1--200nm, the overwhelming majority can be crossed the 1200--1500 mesh sieve less than 100nm.
Another important feature of the present invention is: solid preparation of the present invention disintegrate rapidly, and solid dispersion is good in water, absorb fully, the bioavailability height, the pharmacological action effect that mainly contains effective constituent is significantly higher than conventional formulation.
The pharmaceutical preparation that the present invention is made does not need to add any adjuvant, and is more favourable to human body.
The present invention has also created the novel form that pill, powder, tablet, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution of nano antivirus medicine etc. had no precedent in the past.
Pharmaceutical preparation of the present invention can be used for the treatment of conditions such as flu, inflammation of upper respiratory tract, bronchitis, pneumonia, parotitis and epidemic hemorrhagic conjunctivitis due to the viral infection, and clinical efficacy significantly is better than traditional antiviral bolt.
The present invention's added solvent in microwave extracting is water or ethanol.
The present invention carries out in the concentrating under reduced pressure step at extract, and its concentrating under reduced pressure is conventional scheme.
Embodiment 1:
Prepare nano raw material by preceding method:
180 parts of 35 parts of nano Radix Isatidis of 80 parts of nanometer Rhizoma Anemarrhenaes of nanometer Gypsum Fibrosum
35 parts of 45 parts of nanometer Rhizoma Acori Graminei of 65 parts of nanometer Radix Rehmanniae of nanometer Fructus Forsythiae
40 parts of 35 parts of nanometer Herba Pogostemonis of 85 parts of nanometer Radix Curcumaes of nanometer Rhizoma Phragmitis
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent capsules agent standard, do not add adjuvant, do not granulate, directly divide encapsulated with the fully-automatic capsule racking machine, make capsule, every capsules content of dispersion is the 0.1--0.6 gram, and the patient takes the 1-5 grain at every turn, and take 1-4 every day.
Embodiment 2:
Prepare nano raw material by preceding method:
180 parts of 35 parts of nano Radix Isatidis of 80 parts of nanometer Rhizoma Anemarrhenaes of nanometer Gypsum Fibrosum
35 parts of 45 parts of nanometer Rhizoma Acori Graminei of 65 parts of nanometer Radix Rehmanniae of nanometer Fructus Forsythiae
40 parts of 35 parts of nanometer Herba Pogostemonis of 85 parts of nanometer Radix Curcumaes of nanometer Rhizoma Phragmitis
Production method is as follows:
In the GMP cleaning shop, with the above-mentioned nanometer prepared slices of Chinese crude drugs or the described mixed of powder good after, according to 2000 editions two-shift system agent of Chinese Pharmacopoeia powder needle injection standard, do not add any adjuvant, make the nano antivirus powder needle injection, every injection content is the 5-20 milligram, each consumption is that 1-2 props up, and use 1-3 every day.
Embodiment 3:
Prepare nano raw material by preceding method:
180 parts of 35 parts of nano Radix Isatidis of 80 parts of nanometer Rhizoma Anemarrhenaes of nanometer Gypsum Fibrosum
35 parts of 45 parts of nanometer Rhizoma Acori Graminei of 65 parts of nanometer Radix Rehmanniae of nanometer Fructus Forsythiae
40 parts of 35 parts of nanometer Herba Pogostemonis of 85 parts of nanometer Radix Curcumaes of nanometer Rhizoma Phragmitis
Production method is as follows:
In the GMP cleaning shop, with the above-mentioned nanometer prepared slices of Chinese crude drugs or powder by described mixed good after, according to 2000 editions two-shift system agent of Chinese Pharmacopoeia membrane standard, filmogen adopts polyvinyl alcohol, make the nano antivirus membrane, every membrane area size is the 2-100 square centimeter, and content of dispersion is the 1-50 gram, every medicine film pasted 1-7 days, pasted the medicine position: abdominal part, back, chest.
Claims (6)
1, a kind of nano antivirus medicine is characterized in that it is the medicament that the nano raw material of following weight proportioning is made:
Nanometer Gypsum Fibrosum 50-120 part nanometer Rhizoma Anemarrhenae 15-60 part nano Radix Isatidis 120-250 part
Nanometer Fructus Forsythiae 40-90 part nanometer Radix Rehmanniae 25-80 part nanometer Rhizoma Acori Graminei 20-55 part
Nanometer Rhizoma Phragmitis 50-120 part nanometer Radix Curcumae 20-55 part nanometer Herba Pogostemonis 25-60 part
And adopt following method to make: to select the formula Chinese drug material to concoct and be processed into the prepared slices of Chinese crude drugs; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1-10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 30--60 ℃ of temperature, under 0 to the 0.05MPa pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters-990 meter per seconds, promptly makes the nanometer prepared slices of Chinese crude drugs.
2, nano antivirus medicine according to claim 1, wherein the weight proportion of each nano raw material is:
Nanometer Gypsum Fibrosum 60-100 part nanometer Rhizoma Anemarrhenae 20-50 part nano Radix Isatidis 150-210 part
Nanometer Fructus Forsythiae 50-80 part nanometer Radix Rehmanniae 30-60 part nanometer Rhizoma Acori Graminei 25-45 part
Nanometer Rhizoma Phragmitis 60-100 part nanometer Radix Curcumae 25-45 part nanometer Herba Pogostemonis 30-50 part
3, nano antivirus medicine according to claim 1, wherein the weight proportion of each nano raw material is:
180 parts of 35 parts of nano Radix Isatidis of 80 parts of nanometer Rhizoma Anemarrhenaes of nanometer Gypsum Fibrosum
35 parts of 45 parts of nanometer Rhizoma Acori Graminei of 65 parts of nanometer Radix Rehmanniae of nanometer Fructus Forsythiae
40 parts of 35 parts of nanometer Herba Pogostemonis of 85 parts of nanometer Radix Curcumaes of nanometer Rhizoma Phragmitis
4,, it is characterized in that said medicine is pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution according to claim 1 or 2 or 3 described nano antivirus medicines.
5,, it is characterized in that this method comprises the steps: to select the formula Chinese drug material to concoct and is processed into the prepared slices of Chinese crude drugs according to the pharmaceutical methods of claim 1 or 2 or 3 described nano antivirus medicines; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1-10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 30--60 ℃ of temperature, under 0 to the 0.05MPa pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters-990 meter per seconds, promptly makes the nanometer prepared slices of Chinese crude drugs.
6, wherein respectively distinguish the flavor of Chinese medicine in the ratio of prescription or Chinese crude drug concoct be processed into the prepared slices of Chinese crude drugs after mixing, or after making the nanometer prepared slices of Chinese crude drugs mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01102353 CN1368122A (en) | 2001-02-02 | 2001-02-02 | Nano antivirus medicine and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01102353 CN1368122A (en) | 2001-02-02 | 2001-02-02 | Nano antivirus medicine and its preparing process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1368122A true CN1368122A (en) | 2002-09-11 |
Family
ID=4652655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01102353 Pending CN1368122A (en) | 2001-02-02 | 2001-02-02 | Nano antivirus medicine and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1368122A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1306930C (en) * | 2003-05-05 | 2007-03-28 | 广州白云山医药科技发展有限公司 | Soft antiviral capsule and its prepn |
| CN105477558A (en) * | 2016-01-04 | 2016-04-13 | 成都富豪斯生物科技有限公司 | Decoction drug for treating upper respiratory infection and preparation method thereof |
-
2001
- 2001-02-02 CN CN 01102353 patent/CN1368122A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1306930C (en) * | 2003-05-05 | 2007-03-28 | 广州白云山医药科技发展有限公司 | Soft antiviral capsule and its prepn |
| CN105477558A (en) * | 2016-01-04 | 2016-04-13 | 成都富豪斯生物科技有限公司 | Decoction drug for treating upper respiratory infection and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1368110A (en) | Nano medicine 'Yaoai' and its preparing process | |
| CN1368122A (en) | Nano antivirus medicine and its preparing process | |
| CN1368208A (en) | Nano medicine 'Ganfu' and its preparing process | |
| CN1365676A (en) | Nano medicine 'Compound berberine' and its preparing process | |
| CN1365703A (en) | Nano medicine for child to induce diaphoresis and its preparing process | |
| CN1365757A (en) | Nano antitussive asthma-relieving medicine and its preparing process | |
| CN1365810A (en) | Nano medicine 'Guishao Dihuang' and its preparing process | |
| CN1368203A (en) | Nano medicine 'Zanglian' and its preparing process | |
| CN1364505A (en) | Nano seven ingredient iron filing medicine and its prepairng method | |
| CN1364581A (en) | Nano Children heat fast clearing away medicine and its preparing method | |
| CN1368071A (en) | Nano medicine 'Qianzihong' and its preparing process | |
| CN1366894A (en) | Nano lung-clearing anti-inflammatory preparation medicine and preparation method thereof | |
| CN1366978A (en) | Nane common cold-fever-abating preparation medicine and preparation method | |
| CN1362108A (en) | Nano rhinitis-treating drop medicine and its preparation | |
| CN1365813A (en) | Nano human placenta medicine and its preparing process | |
| CN1365683A (en) | Nano medicine 'Dahuang Qingwei' and its preparing process | |
| CN1368200A (en) | Nano medicine 'Emuqingfei' and its preparing process | |
| CN1365672A (en) | Nano medicine for treating baby obesity and its preparing process | |
| CN1368060A (en) | Nano defervescent and digestion-promoting medicine and its preparing process | |
| CN1366899A (en) | Nano dizziness-clearing preparation medicine and preparation method thereof | |
| CN1365768A (en) | Nano 6-component Anxiao medicine and its preparing process | |
| CN1365727A (en) | Nano cinammon twigs medicine and its preparing process | |
| CN1368259A (en) | Nano medicine 'Yangweining' and its preparing process | |
| CN1365796A (en) | Nano medicine 'Xiaoer Qingyan' and its preparing process | |
| CN1366965A (en) | Nano wind-cold Ganmaoning preparation medicine and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |